The FDA approved an oral extended-release formulation of levodopa and carbidopa known as IPX203 (Crexont) to treat Parkinson's disease, Amneal Pharmaceuticals announced Wednesday. The treatment is a ...
The Centre bans oral nimesulide formulations above 100mg due to health risks, allowing only lower doses and non-oral ...
Haryana & Telangana begin crackdown on nimesulide above 100 mg in immediate-release dosage forms: Peethaambaran Kunnathoor, Chennai Saturday, January 3, 2026, 08:00 Hrs [IST] Foll ...
ICMR recommended that nimesulide not be used in pregnant, lactating and women planning for pregnancy, patients with kidney or ...
The government has banned the manufacture, sale and distribution of all oral formulations of pain and fever medications, ...
India bans oral Nimesulide medicines above 100 mg in immediate-release form, citing health risks and availability of safer ...
The Centre has banned the manufacture, sale, and distribution of all oral formulations containing the painkiller nimesulide ...
5don MSN
Govt bans manufacture, sale of oral formulations containing nimesulide above 100 mg-Here's why
The Central government has banned manufacture, sale and distribution of a painkiller, citing potential health risks. All oral ...
This interview addresses the challenges and complexities of developing and manufacturing controlled-release drug formulations. Could you introduce yourself and your expertise in drug development and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback